The global IV bags market size was estimated to be USD 2.13 billion in 2023 and is expected to reach at USD 6.68 billion by 2034 with a CAGR of 10.95% during the forecast period 2024-2034. The prevalence of chronic diseases is on the rise, accompanied by an increasing number of surgeries, road accidents, and a growing elderly population. IV bags are becoming more accessible and affordable, contributing to their widespread use in the healthcare sector. There is a growing demand for efficient blood storage methods, especially with the expanding reach of healthcare facilities in remote areas. Additionally, the adoption of parenteral nutrition therapy is on the rise, supported by increased regulatory approvals and a surge in product launches, leading to a greater variety of IV bag options available in the market are some of the key factors boosting the market growth.
Surge in product launches, leading to a greater variety of IV bag options available in the market is predicted to boost the market growth during the forecast period. In the current global scenario, the popularity of IV therapy is on the rise, driven by the increasing prevalence of chronic diseases. The demand for IV therapy, known for its capacity to elevate electrolyte levels in the human body, is gaining momentum in the treatment of conditions like diarrhea and chronic fever. This trend has spurred efforts to innovate various methods of fluid injection, including the use of IV bags. The sales of IV bags are anticipated to surge as competitors recognize the adoption of a cost-effective yet efficient approach to fluid injection in comparison to infusion pumps. For instance, in April 2022, B. Braun introduced the B. Braun Exquisica IV bag, an advanced generation of intravenous bags crafted to enhance user-friendliness and patient comfort. These bags feature a pliable material for easy handling and are equipped with a built-in infusion line, designed to mitigate the risk of leaks.
By material type, polypropylene was the highest revenue-grossing segment in the global IV bags market in 2023. Polypropylene IV bags are preferred for administering and storing IV fluids due to their cost-effectiveness, high flexural strength resulting from their semi-crystalline nature, moisture resistance, and strong fatigue resistance. These advantages contribute to an increased demand for polypropylene bags, driven by the growing burden of chronic diseases and companies prioritizing the development of high-quality IV bags. For instance, in June 2022, Gufic Biosciences introduced Dual-Chamber Polypropylene Bags, free of DEHP, featuring peelable aluminum foil. These high-quality bags facilitate the storage of volatile medications, requiring reconstitution just prior to patient administration. Additionally, polyethylene is predicted to grow at fastest CAGR during the forecast period owing to the increasing collaborations and partnerships among market players, key industry leaders are making concerted efforts to develop innovative products as a strategy to gain a competitive edge.
By capacity, 0-250 ml was the highest revenue-grossing segment in the global IV bags market in 2023 owing to the rising number of patients suffering from various infectious diseases, increasing demand by blood bank centers, and growing introduction of new products. For instance, in February 2023, Bowmed Ibisqus has unveiled a pre-prepared Levofloxacin bag, complete with a protective foil covering to safeguard the product from light exposure. Crucial product information is conveniently displayed on the overwrap for quick reference. Additionally, is predicted to grow at fastest CAGR during the forecast period owing to the rising demand for large quantities of IV bags for storage and surge in number of patient admission to hospitals.
By chamber type, single chamber was the highest revenue-grossing segment in the global IV bags market in 2023 owing to the utilization of single-chamber IV bags is presently widespread, driven by a notable shift from glass containers to plastic bags. This transition is attributed to the advantages of plastic bags, including ease in handling, transportation, and disposal. Intravenous solutions such as irrigation fluids, drip bags, and sterile water are commonly delivered through these bags. Additionally, the market is witnessing increased mergers and acquisitions among industry players. Consequently, the prevalence of single-chamber bags is anticipated to expand significantly throughout the forecast period. For instance, in January 2022, ICU Medical completed the acquisition of Smiths Medical from Smiths Group plc. This strategic move added Smiths Medical's syringe and ambulatory infusion devices, vascular access, and vital care products to the ICU Medical portfolio, establishing the company as a prominent player in infusion therapy with an enhanced global presence. Additionally, multi-chambered is predicted to grow at fastest CAGR during the forecast period owing to their remarkable stability, flexibility under high pressure, exceptional transparency, durability, and ability to be reused, these containers find extensive use in the pharmaceutical industry. Their popularity is rising, especially in emergency scenarios, and there is an increasing trend of utilizing multi-chambered containers for various purposes like parenteral nutrition and drug reconstitution. Moreover, the availability of customized product options further contributes to their widespread adoption.
By end-user, hospitals was the highest revenue-grossing segment in the global IV bags market in 2023. Hospitals leverage their significant patient volume and the extensive array of medical services they offer. IV bags play a crucial role in hospitals, being extensively used for delivering medication, fluids, and blood products to patients. Hospitals capitalize on established supply chain networks and efficient procurement procedures, enabling them to acquire IV bags in substantial quantities at discounted rates. For instance, in November 2022, QuVa Pharma, Inc. revealed the introduction of a dual-sided single label for its range of compounded IV bags. The creation of these innovative labels was a collaborative effort with customers and aligned with the Institute of Safe Medication Practices' (ISMP) 2022 best practice recommendations. Additionally, home health care is predicted to grow at fastest CAGR during the forecast period owing to the rising need for home-based healthcare services and the escalating prevalence of chronic illnesses.
North America region is anticipated for the highest revenue share during the forecast period owing to the uptick in chronic diseases, expanding elderly demographic, surge in healthcare expenditures, stringent regulations focusing on patient care and safety, a rising number of product launches, an increasing prevalence of transplant procedures, and a growth in product approvals. For instance, in February 2022, The FDA has given B. Braun Medical permission to start up at its recently constructed IV saline solution production plant in Daytona Beach, Florida. The facility spent USD 1 billion on its US manufacturing and supply chain to address shortages of IV fluids and is anticipated to produce 0.9% sodium chloride for injection. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in patients necessitating intravenous therapy, the extensive adoption of parenteral nutrition treatment, and the high incidence of chronic ailments like cancer, diabetes, and renal disease contribute to the escalating healthcare costs. The growing need for improved healthcare services, a rising elderly population, heightened pharmaceutical company outsourcing in production, and the continual introduction of new products. For instance, in December 2022, Reclast for osteoporosis treatment, presented in intravenous (i.v.) infusion bags, has been introduced by Asahi Kasei Pharma and is now included in Japan's National Health Insurance (NHI) drug price standard.
Surge in product launches, leading to a greater variety of IV bag options available in the market is predicted to boost the market growth during the forecast period. In the current global scenario, the popularity of IV therapy is on the rise, driven by the increasing prevalence of chronic diseases. The demand for IV therapy, known for its capacity to elevate electrolyte levels in the human body, is gaining momentum in the treatment of conditions like diarrhea and chronic fever. This trend has spurred efforts to innovate various methods of fluid injection, including the use of IV bags. The sales of IV bags are anticipated to surge as competitors recognize the adoption of a cost-effective yet efficient approach to fluid injection in comparison to infusion pumps. For instance, in April 2022, B. Braun introduced the B. Braun Exquisica IV bag, an advanced generation of intravenous bags crafted to enhance user-friendliness and patient comfort. These bags feature a pliable material for easy handling and are equipped with a built-in infusion line, designed to mitigate the risk of leaks.
By material type, polypropylene was the highest revenue-grossing segment in the global IV bags market in 2023. Polypropylene IV bags are preferred for administering and storing IV fluids due to their cost-effectiveness, high flexural strength resulting from their semi-crystalline nature, moisture resistance, and strong fatigue resistance. These advantages contribute to an increased demand for polypropylene bags, driven by the growing burden of chronic diseases and companies prioritizing the development of high-quality IV bags. For instance, in June 2022, Gufic Biosciences introduced Dual-Chamber Polypropylene Bags, free of DEHP, featuring peelable aluminum foil. These high-quality bags facilitate the storage of volatile medications, requiring reconstitution just prior to patient administration. Additionally, polyethylene is predicted to grow at fastest CAGR during the forecast period owing to the increasing collaborations and partnerships among market players, key industry leaders are making concerted efforts to develop innovative products as a strategy to gain a competitive edge.
By capacity, 0-250 ml was the highest revenue-grossing segment in the global IV bags market in 2023 owing to the rising number of patients suffering from various infectious diseases, increasing demand by blood bank centers, and growing introduction of new products. For instance, in February 2023, Bowmed Ibisqus has unveiled a pre-prepared Levofloxacin bag, complete with a protective foil covering to safeguard the product from light exposure. Crucial product information is conveniently displayed on the overwrap for quick reference. Additionally, is predicted to grow at fastest CAGR during the forecast period owing to the rising demand for large quantities of IV bags for storage and surge in number of patient admission to hospitals.
By chamber type, single chamber was the highest revenue-grossing segment in the global IV bags market in 2023 owing to the utilization of single-chamber IV bags is presently widespread, driven by a notable shift from glass containers to plastic bags. This transition is attributed to the advantages of plastic bags, including ease in handling, transportation, and disposal. Intravenous solutions such as irrigation fluids, drip bags, and sterile water are commonly delivered through these bags. Additionally, the market is witnessing increased mergers and acquisitions among industry players. Consequently, the prevalence of single-chamber bags is anticipated to expand significantly throughout the forecast period. For instance, in January 2022, ICU Medical completed the acquisition of Smiths Medical from Smiths Group plc. This strategic move added Smiths Medical's syringe and ambulatory infusion devices, vascular access, and vital care products to the ICU Medical portfolio, establishing the company as a prominent player in infusion therapy with an enhanced global presence. Additionally, multi-chambered is predicted to grow at fastest CAGR during the forecast period owing to their remarkable stability, flexibility under high pressure, exceptional transparency, durability, and ability to be reused, these containers find extensive use in the pharmaceutical industry. Their popularity is rising, especially in emergency scenarios, and there is an increasing trend of utilizing multi-chambered containers for various purposes like parenteral nutrition and drug reconstitution. Moreover, the availability of customized product options further contributes to their widespread adoption.
By end-user, hospitals was the highest revenue-grossing segment in the global IV bags market in 2023. Hospitals leverage their significant patient volume and the extensive array of medical services they offer. IV bags play a crucial role in hospitals, being extensively used for delivering medication, fluids, and blood products to patients. Hospitals capitalize on established supply chain networks and efficient procurement procedures, enabling them to acquire IV bags in substantial quantities at discounted rates. For instance, in November 2022, QuVa Pharma, Inc. revealed the introduction of a dual-sided single label for its range of compounded IV bags. The creation of these innovative labels was a collaborative effort with customers and aligned with the Institute of Safe Medication Practices' (ISMP) 2022 best practice recommendations. Additionally, home health care is predicted to grow at fastest CAGR during the forecast period owing to the rising need for home-based healthcare services and the escalating prevalence of chronic illnesses.
North America region is anticipated for the highest revenue share during the forecast period owing to the uptick in chronic diseases, expanding elderly demographic, surge in healthcare expenditures, stringent regulations focusing on patient care and safety, a rising number of product launches, an increasing prevalence of transplant procedures, and a growth in product approvals. For instance, in February 2022, The FDA has given B. Braun Medical permission to start up at its recently constructed IV saline solution production plant in Daytona Beach, Florida. The facility spent USD 1 billion on its US manufacturing and supply chain to address shortages of IV fluids and is anticipated to produce 0.9% sodium chloride for injection. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in patients necessitating intravenous therapy, the extensive adoption of parenteral nutrition treatment, and the high incidence of chronic ailments like cancer, diabetes, and renal disease contribute to the escalating healthcare costs. The growing need for improved healthcare services, a rising elderly population, heightened pharmaceutical company outsourcing in production, and the continual introduction of new products. For instance, in December 2022, Reclast for osteoporosis treatment, presented in intravenous (i.v.) infusion bags, has been introduced by Asahi Kasei Pharma and is now included in Japan's National Health Insurance (NHI) drug price standard.
Segmentation: IV Bags Market Report 2023 - 2034
IV Bags Market Analysis & Forecast by Material Type 2023 - 2034 (Revenue USD Bn)
- Polyvinyl Chloride
- Polypropylene
- Polyethylene
- Other
IV Bags Market Analysis & Forecast by Capacity 2023 - 2034 (Revenue USD Bn)
- 500-1000 ml
- 250-500 ml
- 0-250 ml
IV Bags Market Analysis & Forecast by Chamber Type 2023 - 2034 (Revenue USD Bn)
- Multi Chamber
- Single Chamber
IV Bags Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Home Health Care
- Hospitals
- Others
IV Bags Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. IV Bags Market: Material Type Estimates & Trend Analysis
8. IV Bags Market: Capacity Estimates & Trend Analysis
9. IV Bags Market: Chamber Type Estimates & Trend Analysis
10. IV Bags Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America IV Bags Market
13. Europe Global IV Bags Market
14. Asia Pacific Global IV Bags Market
15. Latin America Global IV Bags Market
16. MEA Global IV Bags Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- B. Braun Medical Inc.
- Technoflex
- ICU Medical Inc.
- Fresenius Kabi
- Polycine GmbH
- Baxter international Inc.
- Haemotronic
- Kraton Corporation
- Sippex IV bags
- MedicoPack
- Otsuka Holdings (Otsuka Pharmaceutical India Private Limited)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 2.13 Billion |
| Forecasted Market Value ( USD | $ 6.68 Billion |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
